The tentative approval for ANDA 218862 was posted to the Drugs@FDA site.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX:
- Amneal Pharmaceuticals backs prior FY24 EPS view 57c-63c, consensus 61c
- Amneal Pharmaceuticals Maintains Transparency with SEC Filing
- Amneal Pharmaceuticals director Patel sells 62,590 class A shares
- Appeals court sides with Amneal over Teva in inhaler patent fight
- Amneal resubmits DHE autoinjector NDA, gets FDA approval for exenatide